Fbxo22 promotes cervical cancer progression via targeting p57kip2 for ubiquitination and degradation

HIGHLIGHTS

• who: Min Lin from the Ethics statement The human tissue study was approved by the ethical committee of the Second Affiliated Hospital of Wenzhou Medical University and conducted have published the research: Fbxo22 promotes cervical cancer progression via targeting p57Kip2 for ubiquitination and degradation, in the Journal: (JOURNAL) of 12/04/2022
• what: The authors report for the first time that ectopic expression of FBXO22 promoted cell viability and inhibited apoptosis in CC cells via promoting the Cell Death and Disease 13:805 ubiquitination and proteasomal degradation of p57Kip2 uncovering a new mechanism by which . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.